Hoppa till innehåll
Pelago Bioscience Logotype for Pelago bioscience
  • Services
    • CETSA®
      • Unbiased Profiling
        • Proteome Wide
        • Selectivity Profiling
      • Targeted Profiling
  • Drug Discovery Phases
    • Target Discovery
      • Target Identification and Deconvolution
    • Lead Generation
      • Primary Screening
      • Hit Confirmation
      • Potency Ranking 
      • Selectivity Profiling
    • Lead Optimization
      • Potency Ranking 
      • Selectivity Profiling
      • Target Identification and Deconvolution
      • Mechanism of Action
      • Translational Studies
    • Preclinical Studies
      • Translational Studies
      • In Vivo Target Engagement
      • Biomarker Discovery
  • About CETSA®
    • Why CETSA?
    • Your key to biological relevance
  • Case Stories
  • About us
    • Our story
    • Our facilities
  • News & Events
  • Blog
  • Contact Us
    • Contact us
    • Career
    • Whistleblowing
  • Scientific Hub

News

New privacy policy

We respect your integrity and ensure that your personal data is processed with the confidentiality and respect that is required. Therefore, We have revised our privacy policy.

Read more

June 15, 2026 News

Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry

June 2, 2026 Conference

Meet us at Oxford Global Drug Discovery Europe 

May 11, 2026 Conference

Meet us at SLAS 2026

Meet us at AACR 2026

February 26, 2026 Conference

Meet us at AACR 2026

More articles
Logotype for Pelago bioscience

Pelago Bioscience AB
Scheeles väg 1
171 65 Solna
Sweden

  • About us
    • Our facilities
  • Drug Discovery Phases
    • Target Discovery
    • Lead Optimization
    • Lead Generation
    • Preclinical Studies
  • About CETSA®
    • Your key to biological relevance
  • News & Events
    • Contact Us
    • Whistleblowing
    • Login
Login
Subscribe to our newsletter

© 2026 Pelago Bioscience

Privacy policy
Let's discuss your project